Hobohm, Lukas
Becattini, Cecilia
Konstantinides, Stavros V.
Casazza, Franco
Lankeit, Mareike http://orcid.org/0000-0001-5211-7997
Funding for this research was provided by:
German Federal Ministry of Education and Research (BMBF 01EO1503)
Article History
Received: 16 September 2019
Accepted: 22 December 2019
First Online: 6 February 2020
Compliance with ethical standards
:
: The authors have reported to the Clinical Research of Cardiology Journal the following: L.H. reports having received lecture honoraria from MSD and Actelion. C. B. reports having received consultancy and lecture honoraria from Bayer, Bristol Myers Squibb and Daiichi Sankyo. S.K. reports having received consultancy and lecture honoraria from Bayer, Boehringer Ingelheim, Daiichi-Sankyo, MSD and Pfizer – Bristol-Myers Squibb; and institutional grants from Actelion, Bayer, Boehringer Ingelheim, Daiichi-Sankyo and Pfizer – Bristol-Myers Squibb. F. C. reports no conflict of interest. M. L. reports having received consultancy and lecture honoraria from Actelion, Bayer, Daiichi-Sankyo, MSD, Pfizer – Bristol-Myers Squibb and research funding from BRAHMS – Thermo Fisher scientific.
: The study protocol was conducted in accordance with the amended Declaration of Helsinki and was approved by the local independent Ethic Committees at the study centres. Informed consent was obtained from all individual participants included in the study.